GlassScriptPhysician profile
Stacey A Murray
NPI 1467633743
$12,590.54
in general payments reported to CMS, 2019-2025
37 companies · $15.77 in 2025
The $15.77 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12K · 2022: $716 · 2025: $15.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $7,875.44 | 2021-2022 | |
| Celgene Corporation | $1,347.64 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $1,063.86 | 2021 | |
| Emd Serono, INC. | $376.31 | 2021-2025 | |
| Lundbeck LLC | $197.97 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $193.31 | 2021 | |
| Novartis Pharmaceuticals Corporation | $174.34 | 2021 | |
| Sunovion Pharmaceuticals INC. | $122.87 | 2021-2022 | |
| Horizon Therapeutics Plc | $120.77 | 2022 | |
| Abbvie INC. | $98.60 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $97.22 | 2021 | |
| Allergan, INC. | $90.34 | 2021 | |
| Amneal Pharmaceuticals LLC | $66.14 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $65.51 | 2021-2022 | |
| Acorda Therapeutics, INC | $54.55 | 2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $51.30 | 2022 | |
| Genzyme Corporation | $49.95 | 2021 | |
| Amgen INC. | $49.77 | 2021 | |
| Banner Life Sciences, LLC | $47.13 | 2021 | |
| Genentech USA, INC. | $43.10 | 2021-2022 | |
| Eisai INC. | $36.94 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $36.45 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $32.42 | 2021 | |
| Avion Pharmaceuticals | $30.41 | 2022 | |
| Kyowa Kirin, INC. | $29.99 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $29.22 | 2021 | |
| Ucb, INC. | $29.02 | 2021 | |
| Grt US Holding, INC. | $21.49 | 2022 | |
| Merz Pharmaceuticals, LLC | $21.29 | 2021 | |
| Genentech, INC. | $20.88 | 2021 | |
| Arbor Pharmaceuticals, INC. | $19.93 | 2022 | |
| Alexion Pharmaceuticals, INC. | $19.21 | 2022 | |
| Mdd US Operations, LLC | $17.72 | 2022 | |
| Ge Healthcare | $17.32 | 2022 | |
| Almatica Pharma LLC | $15.51 | 2021 | |
| Pfizer INC. | $15.26 | 2022 | |
| Sk Life Science, INC. | $11.36 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.